Background: Recently, some studies have showed that miR-200 families act as
analyses showed that the Asian population predicted poor OS. While the Caucasian population did not exhibit an significant association with OS. This discrepancy might result from different hereditary backgrounds and environment exposure. Although these results have indicated that miR-200 families were promising biomarkers to predict prognosis for patients with cancers, there were several limitations in this analysis that would impact its quality. Generally, further studies should be warranted to clarify this question and to provide a new novel idea for routine clinical application.
Conclusion:
Our findings suggest that miR-200 family might be a potentially useful biomarker for predicting cancer prognosis, especially for lung cancer in Asians. 
| MATERIALS AND METHODS

| Search strategy
We searched online in PubMed, EMBASE, and CNKI databases up to October 18, 2016 , to identify relevant studies, with a combination of the following keywords used simultaneously, namely "cancer," "carcinoma," "tumor," "micro-RNA-200 family," "miRNA-
200
," "miR-200," "hazard ratio (HR)," "follow-up," "survival," and "prognosis." We evaluated potentially relevant studies by examining their titles, abstracts, and full texts matching the eligible criteria retrieved.
Studies were considered eligible if they met the following criteria: (i) studies focused on patients with any type of cancers; (ii) studies measuring the expression of miR-200 family in tissue or serum/plasma;
(iii) studies investigating the association between miR-200 family expression and prognosis outcomes. Articles were excluded if they were review articles or letters, not focusing on human carcinomas. Other exclusion criteria included studies lacking key information such as HR, 95% confidence intervals (CIs), and P value, without survival curves.
| Data extraction
We extracted relevant data from included studies and recorded these data based on a standardized form. Extracted data elements included:
(i) the name of first author and publication year; (ii) characteristics of the studied population, including total number of patients, country, 15 The extracted information was summarized in a consistent manner to prevent bias.
| Statistical methods
The aggregation of HRs and 95% CIs was calculated in the following Tierney method. 16 Forest plots were used to estimate the effect of 18 For all analyses, a P value <.05 was considered to be statistically significant, and all the P values were two-sided. All analyses were performed with the STATA 11.0 software (Stata Corp LP, College Station, TX, USA).
| RESULTS
A total of 274 potentially relevant studies were identified from literature search in PubMed, EMBASE and CNKI databases; 257 papers were excluded after manual screening of titles, abstracts and key words, because they were not related to the current study. After reading the full texts of the remaining 17 studies, 12 eligible studies were included for the final analysis. A flow diagram of the study selection process is shown in Figure 1 .
We collected data from enrolled 12 retrospective studies. Table 1 . For prognosis, all the studies analyzed OS and significant heterogeneity between studies was shown (P < .001,
hence, a random-effects model was applied to estimate a pooled HR (HR = 1.54) along with its 95% CI (1.01-2.33). We found that higher expression of miR-200 family significantly associated with poorer OS. Three studies evaluated PFS or RFS, and the results indicated that there was no statistical association ( (Table 2) .
Finally, the funnel plot and Egger tests were used to detect publication bias of the included studies. As shown in Figure 3 , the funnel plot was almost symmetric. In OS meta-analysis, the P value of the
Egger test was .120; therefore, there was no evidence for significant publication bias in the meta-analysis.
| DISCUSSION
Aberrant expression of miRNAs played a crucial role in the area of human carcinomas. [19] [20] [21] Many studies have indicated that miRNAs are considered promising tumor biomarkers for prognosis and potential targets for clinical treatment. 22 As described above, we have tes- 
| CONCLUSION S
In summary, our meta-analysis represents that high level of miR-200 family expression is significantly associated with poor survival in .522
OS, overall survival; PFS, progression-free survival; RFS, recurrence-free survival; HR, hazard ratio; CI, confidence interval.
a
The HRs and 95% CIs of analyzed studies were pooled by the random-effects model if the P value for heterogeneity was <.10 or I 2 was >50%.
b
The HRs and 95% CIs of analyzed studies were pooled by the fixed-effects model if the P value for heterogeneity was more than .10 or I 2 was <50%.
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